Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 2/20 | 0.58 |
| ▸ | LMNA | P02545 | 2/20 | 0.56 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.45 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.44 |
| ▸ | MMP3 | P08254 | 2/20 | 0.43 |
| ▸ | THRA | P10827 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22213807 | 1.00 | NAAA (0.58) | NAAALMNACYP2C19SMN1; SMN2HTT | |
| Cyclohexane SCHEMBL27646533 | 1.00 | NAAA (0.58) | NAAALMNACYP2C19SMN1; SMN2HTT | |
| SCHEMBL3473161 | 0.98 | NAAA (0.56) | NAAALMNACYP2C19SMN1; SMN2HTT | |
| SCHEMBL27617118 | 0.94 | NAAA (0.52) | NAAALMNACYP2C19SMN1; SMN2HTT | |
| Butane SCHEMBL2857848 | 0.93 | NAAA (0.65) | NAAALMNACYP2C19SMN1; SMN2HTT | |
| SCHEMBL258780 | 0.91 | NAAA (0.66) | NAAALMNACYP2C19SMN1; SMN2HTT | |
| SCHEMBL31069913 | 0.91 | NAAA (0.66) | NAAALMNACYP2C19SMN1; SMN2HTT | |
| SCHEMBL7568980 | 0.91 | NAAA (0.66) | NAAALMNACYP2C19SMN1; SMN2HTT | |
| SCHEMBL19690549 | 0.89 | LMNA (0.47) | NAAALMNACYP2C19SMN1; SMN2HTT | |
| SCHEMBL5071456 | 0.89 | LMNA (0.47) | NAAALMNACYP2C19SMN1; SMN2HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118530412-A | Binder for negative electrode, negative electrode slurry, negative electrode, and lithium battery | 深圳好电科技有限公司 | 2024-08-23 | — | — | CN | claimed |
| CN-119931727-A | Fuel composition and application thereof | 中国石油化工股份有限公司 | 2025-05-06 | — | — | CN | disclosed |
| CN-119931726-A | Smoke-reducing fuel composition and application thereof | 中国石油化工股份有限公司 | 2025-05-06 | — | — | CN | disclosed |
| US-20250076301-A1 | BIOMARKER FOR PROSTATE CANCER | NATIONAL TAIWAN UNIVERSITY (TW) | 2025-03-06 | — | — | US | disclosed |
| CN-118530412-A | Binder for negative electrode, negative electrode slurry, negative electrode, and lithium battery | 深圳好电科技有限公司 | 2024-08-23 | — | — | CN | disclosed |
| CN-117050792-A | Diesel antiwear agent composition, preparation method thereof and diesel oil composition | 中国石油化工股份有限公司 | 2023-11-14 | — | — | CN | disclosed |
| CN-113462442-B | Diesel antiwear agent composition, preparation method thereof and diesel oil composition | 中国石油化工股份有限公司 | 2023-06-09 | — | — | CN | disclosed |
| WO-2023017805-A1 | POLYPROPYLENE COMPOSITION AND INJECTION-MOLDED ARTICLE | サンアロマー株式会社 | 2023-02-16 | — | — | WO | disclosed |
| CN-115537242-A | Diesel antiwear agent composition, preparation method thereof and diesel composition | 中国石油化工股份有限公司 | 2022-12-30 | — | — | CN | disclosed |
| CN-115141663-A | Additive for improving lubricating performance of gasoline and gasoline composition | 中国石油化工股份有限公司 | 2022-10-04 | — | — | CN | disclosed |
| US-20160185823-A1 | ANTIMICROBIAL POLYMYXINS FOR TREATMENT OF BACTERIAL INFECTIONS | MICURX PHARMACEUTICALS, INC. | 2016-06-30 | — | — | US | disclosed |
| WO-2016100578-A2 | ANTIMICROBIAL POLYMYXINS FOR TREATMENT OF BACTERIAL INFECTIONS | MICURX PHARMACEUTICALS, INC. (US) | 2016-06-23 | — | — | WO | disclosed |
| US-8586731-B2 | Hydrophobic polysaccharides with diester- or carbonate ester-containing linkages having enhanced degradation | SURMODICS, INC. (US) | 2013-11-19 | — | — | US | disclosed |
| CN-103003353-A | Thermoplastic elastomeric compositions | EXXONMOBIL CHEM PATENTS INC | 2013-03-27 | — | — | CN | disclosed |
| US-20100316687-A1 | HYDROPHOBIC POLYSACCHARIDES WITH DIESTER- OR CARBONATE ESTER-CONTAINING LINKAGES HAVING ENHANCED DEGRADATION | SURMODICS MD, LLC | 2010-12-16 | — | — | US | disclosed |
| CN-101031577-A | Poly (arylene ether) composition | GEN ELECTRIC (US) | 2007-09-05 | — | — | CN | disclosed |
| CN-100334161-C | Process for preparing DPP pigment | UNIV EAST CHINA SCIENCE & TECH (CN) | 2007-08-29 | — | — | CN | disclosed |
| US-20070099096-A1 | Dye-containing curable composition, color filter and method of producing thereof | FUJIFILM CORPORATION | 2007-05-03 | — | — | US | disclosed |
| US-5198452-A | Leukotriene antagonist, lipoxygenase or cyclooxygenase inhibitors, antihistamines or antiallergens | YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) | 1993-03-30 | — | — | US | disclosed |
| EP-0466125-A2 | Styryl compounds and their pharmaceutical use | YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) | 1992-01-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100316687-A1 | HYDROPHOBIC POLYSACCHARIDES WITH DIESTER- OR CARBONATE ESTER-CONTAINING LINKAGES HAVING ENHANCED DEGRADATION | CD44, SI, ENGASE | NAAA 1210/4885LMNA 1409/4885CYP2C19 876/4885 |
| US-20160185823-A1 | ANTIMICROBIAL POLYMYXINS FOR TREATMENT OF BACTERIAL INFECTIONS | VIP, AQP1, PEF1 | NAAA 632/4885LMNA 660/4885CYP2C19 2690/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.